Dasmahapatra G, Rahmani M, Dent P, Grant S. The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism. Blood. 2006;107(1):232-240
- PMID: 31126918
- PMCID: PMC6634956
- DOI: 10.1182/blood-2019-05-901215
Dasmahapatra G, Rahmani M, Dent P, Grant S. The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism. Blood. 2006;107(1):232-240
Retraction of
-
The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism.Blood. 2006 Jan 1;107(1):232-40. doi: 10.1182/blood-2005-06-2302. Epub 2005 Sep 15. Blood. 2006. Retraction in: Blood. 2019 Jul 4;134(1):95. doi: 10.1182/blood-2019-05-901215. PMID: 16166589 Free PMC article. Retracted.
Similar articles
-
The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism.Blood. 2006 Jan 1;107(1):232-40. doi: 10.1182/blood-2005-06-2302. Epub 2005 Sep 15. Blood. 2006. Retraction in: Blood. 2019 Jul 4;134(1):95. doi: 10.1182/blood-2019-05-901215. PMID: 16166589 Free PMC article. Retracted.
-
Naja nigricollis CMS-9 enhances the mitochondria-mediated death pathway in adaphostin-treated human leukaemia U937 cells.Clin Exp Pharmacol Physiol. 2011 Nov;38(11):755-63. doi: 10.1111/j.1440-1681.2011.05585.x. Clin Exp Pharmacol Physiol. 2011. PMID: 21824174
-
Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK- and AKT-dependent process.Oncogene. 2004 Feb 19;23(7):1364-76. doi: 10.1038/sj.onc.1207248. Oncogene. 2004. PMID: 14647418
-
Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl.Leuk Res. 2006 Oct;30(10):1263-72. doi: 10.1016/j.leukres.2006.01.005. Epub 2006 Feb 14. Leuk Res. 2006. PMID: 16481037
-
Antiproliferative and proapoptotic effects of proteasome inhibitors and their combination with histone deacetylase inhibitors on leukemia cells.Cardiovasc Hematol Disord Drug Targets. 2009 Mar;9(1):62-77. doi: 10.2174/187152909787581372. Cardiovasc Hematol Disord Drug Targets. 2009. PMID: 19275578 Review.
Publication types
LinkOut - more resources
Full Text Sources